AVITA Medical to Host Investor Webinar Briefing
VALENCIA, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ:RCEL, ASX:AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on December 5, 2023, at 2:00 p.m. (PST) / December 6, 2023, at 9:00 a.m. (AEDT).
Related news for (RCEL)
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- AVITA Medical Appoints New Non-Executive Member to the Board of Directors